share_log

亚虹医药:江苏亚虹医药科技股份有限公司自愿披露关于在2024年国际光动力与光诊断大会上发布APL-1702国际多中心Ⅲ期临床试验相关数据的公告

Yahong Pharmaceutical: Jiangsu Yahong Pharmaceutical Technology Co., Ltd. voluntarily disclosed the announcement on the release of data related to the APL-1702 International Multi-Center Phase III Clinical Trial at the 2024 International Photodynamic and Photodiagnostic Conference

SZSI ·  Sep 17, 2024 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more